Fanapt FDA Approval History
Last updated by Judith Stewart, BPharm on April 4, 2024.
FDA Approved: Yes (First approved May 6, 2009)
Brand name: Fanapt
Generic name: iloperidone
Dosage form: Tablets
Company: Vanda Pharmaceuticals Inc.
Treatment for: Schizophrenia, Bipolar Disorder
Fanapt (iloperidone) is a 5HT2/D2 antagonist (atypical) antipsychotic for the treatment of schizophrenia, and the acute treatment of manic or mixed episodes associated with bipolar I disorder in adults.
Development timeline for Fanapt
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.